Balaxi Pharma Share Price

NSE: BALAXI
|
Trading

₹ 22.22

+₹0.09 (0.41%)
1D
Last updated 16 Oct, 2026, 15:13 IST

Balaxi Pharma Share Price Today

As of 16 Oct 2026, Balaxi Pharma share price is ₹22.22. The stock opened at ₹22.60, compared to its previous close of ₹22.13. During today's trading session, Balaxi Pharma share price moved in the range of ₹21.80 to ₹22.60, with an average price of ₹22.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.20 and a high of ₹43.85. On the performance front, Balaxi Pharma share price has declined by 11.30% over the last six months and is down 47.27% on a year-on-year basis.

₹21.80
0.41% up today
₹22.60
1D LOW
1D HIGH

Balaxi Pharma Returns Calculator

Volume
12,717
Average traded price
₹22.15
Last traded time
03:13:12 16 Oct
Last traded quantity
1
Circuit
L
H
₹17.71
₹26.55
52-week
L
H
₹15.20
₹43.85
Mkt Cap Cr
122.45
P/E
50.3
P/B
0.49
ROA
0.72%
ROE
0.57%
ROCE
3.0%
Quick Ratio
2.7
EV/EBITDA
13.09
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Balaxi Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Balaxi Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Balaxi Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,426.9134.865.0511.19%13.74%17.33%2.3121.26
Divis Laboratories2,39,714.1582.0514.3214.6%15.32%19.56%3.554.34
Torrent Pharmaceuticals1,74,740.9981.2620.834.87%25.49%13.85%0.7537.52
Zydus Lifesciences1,13,790.2524.784.28.57%18.59%17.35%0.9114.96
Laurus Labs1,09,143.07100.120.5910.38%16.77%16.14%0.6853.87
Cipla1,07,745.7032.113.137.92%11.27%14.95%2.518.02
Dr. Reddy's Laboratories1,01,338.5332.012.685.48%11.07%12.54%1.3516.1
Mankind Pharma97,263.8647.045.977.36%11.74%13.13%0.7425.36
Aurobindo Pharma96,375.8025.972.546.34%9.25%11.76%1.1512.24
Lupin89,391.0416.143.9914.47%23.76%24.88%1.429.55

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Balaxi Pharma

ISIN
INE618N01022
Sector Market Cap
₹ 122.45 Cr

Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.

Balaxi Pharma Financial Highlights

  • Revenue: Balaxi Pharma reported revenue of ₹272.99 crore in FY26 vs ₹288.84 crore in FY25. It showed a decrease of 5.49% on a yearly basis.
  • Operating Profit: Balaxi Pharma reported an operating profit of ₹5.29 crore in FY26 vs ₹28.67 crore in FY25. It showed a decrease of 81.55% on a year-on-year basis.
  • Net Profit: Balaxi Pharma reported a net profit of ₹1.42 crore in FY26 vs ₹25.07 crore in FY25. It showed a decrease of 94.34% on a yearly basis.

Balaxi Pharma Quarterly Result Highlights

  • Balaxi Pharma reported revenue of ₹79.69 crore in Jun 2026, compared with ₹73.63 crore in Mar 2026, representing an increase of 8.23% on a quarter-on-quarter (QoQ) basis.
  • Balaxi Pharma reported an operating profit of ₹2.09 crore in Jun 2026, compared with ₹1.40 crore in Mar 2026, representing an increase of 49.29% on a quarter-on-quarter (QoQ) basis.
  • Balaxi Pharma reported a profit of ₹1.30 crore in Jun 2026, compared with ₹0.61 crore in Mar 2026, reflecting an increase of 113.11% on a QoQ basis.
  • The earnings per share (EPS) of Balaxi Pharma stood at ₹0.26 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
65.99%
FII
0.00%
Other DII
2.56%
Retail and other
31.45%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20253.50%
Dec 20251.74%
Mar 20260.00%
Jun 20260.00%
1 day
-0.23%
1 week
+0.18%
1 month
-4.28%
1 year
-47.27%
3 years
-74.97%
5 years
-81.41%
Day
Open / Close
Change %
15 Oct 26
₹22.40 / ₹22.13
-0.23%
14 Oct 26
₹22.40 / ₹22.18
-0.05%
13 Oct 26
₹22.58 / ₹22.19
-0.76%
12 Oct 26
₹22.33 / ₹22.36
+0.13%
Show more

Balaxi Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹270.17₹292.56₹241.29₹336.43
Other Income₹2.82-₹3.72₹0.63₹2.64
Total Revenue₹272.99₹288.84₹241.93₹339.07
Total Expenses₹267.70₹260.18₹201.62₹282.15
Profit Before Tax₹5.29₹28.67₹2.02₹56.92
Tax₹3.88₹3.60₹4.40₹10.96
Profit After Tax₹1.42₹25.07-₹2.39₹45.96
EPS - Basic₹0.26₹4.54-₹0.46₹45.81
EPS - Diluted₹0.26₹4.54-₹0.46₹45.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.29₹28.67₹2.02₹56.92
Income before WC changes₹27.27₹36.10₹0.87₹64.96
Change in Assets-₹32.90-₹55.02₹14.35-₹31.74
Change in Liabilities₹5.85-₹12.87-₹3.67-₹15.05
Change in WC-₹27.05-₹67.89₹10.68-₹46.79
Cash flow from Operations-₹4.50-₹35.00₹4.87₹6.08
Cash flow from Investing-₹20.78-₹21.76-₹1.05-₹10.57
Cash flow from Financing₹0.44₹33.88₹30.25₹25.51
Total Cash Flow-₹24.84-₹22.89₹34.07₹21.02
Cash (Start of the year)₹39.40₹62.29₹28.21₹7.19
Cash (End of the year)₹14.56₹39.40₹62.29₹28.21

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹85.60₹67.58₹48.17₹46.16
Current Assets₹251.43₹242.77₹210.17₹193.51
Total Assets₹337.03₹310.34₹258.34₹239.67
Current Liabilities₹62.16₹54.53₹54.20₹53.13
Net Current Asset₹189.27₹188.23₹155.97₹140.38
Non-Current Liabilities₹25.80₹24.07₹2.78₹3.66
Equity Capital₹249.08₹231.74₹201.36₹182.88
Total Equity & Liabilities₹337.03₹310.34₹258.34₹239.67

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹80.85₹60.99₹70.20₹108.14
Other Income₹9.67₹5.37₹2.40₹6.60
Total Revenue₹90.52₹66.36₹72.59₹114.74
Total Expenses₹83.49₹61.07₹67.01₹92.29
Profit Before Tax₹7.03₹5.29₹5.58₹22.45
Tax₹1.89₹1.69₹1.93₹6.23
Profit After Tax₹5.15₹3.60₹3.65₹16.22
EPS - Basic₹0.93₹0.65₹0.71₹16.17
EPS - Diluted₹0.93₹0.65₹0.71₹16.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹7.03₹5.29₹5.58₹22.45
Income before WC changes₹10.43₹7.80₹7.63₹23.43
Change in Assets₹25.98-₹10.93₹0.57-₹27.37
Change in Liabilities₹9.16-₹2.84-₹4.96₹2.29
Change in WC₹35.14-₹13.77-₹4.39-₹25.08
Cash flow from Operations₹43.87-₹7.60-₹1.83-₹7.07
Cash flow from Investing-₹67.77-₹24.98₹0.46-₹2.29
Cash flow from Financing₹0.54₹17.21₹27.55₹26.39
Total Cash Flow-₹23.35-₹15.37₹26.19₹17.03
Cash (Start of the year)₹28.68₹44.06₹17.87₹0.84
Cash (End of the year)₹5.33₹28.68₹44.06₹17.88

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹121.57₹54.84₹31.46₹30.70
Current Assets₹70.60₹119.60₹122.90₹99.02
Total Assets₹192.17₹174.45₹154.36₹129.72
Current Liabilities₹55.73₹43.76₹30.04₹34.83
Net Current Asset₹14.87₹75.84₹92.86₹64.19
Non-Current Liabilities₹3.44₹2.83₹2.78₹2.79
Equity Capital₹133.00₹127.85₹121.55₹92.11
Total Equity & Liabilities₹192.17₹174.45₹154.36₹129.72
* All values are in INR Crore
Qty
Bid
198
22.05
200
22.01
406
22
51
21.9
1195
21.8
Ask
Qty
22.22
60
22.24
130
22.25
750
22.42
66
22.43
50
Bid Total: 2050
Ask Total: 1056
Buy orders: 66%
Sell orders: 34%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
41.01
Neutral
ATR (14)
1.11
Neutral
STOCH(9,6)
44.26
Neutral
STOCH RSI (14)
14.24
Bullish
ADX(9)
39.89
Bearish
UO(9)
41.33
Neutral
ROC(12)
-1.16
Bearish
WillR(14)
-54.62
Neutral
Period
Simple value
Exponential vaue
5D
22.24
22.22
10D
22.34
22.36
20D
22.66
22.62
50D
23.22
23.1
100D
23.66
23.39
Volume trend — traded volume by day
16 Oct0L
15 Oct0L
14 Oct0L
13 Oct0L
12 Oct0L
9 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Balaxi Pharma
Trading
Add Stock
Add Another

Balaxi Pharma Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.